96980-64-2

Basic information

• Product Name: 3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE
• Synonyms: N1-(3-CHLORO-4-FLUOROPHENYL)-2-CHLOROACETAMIDE;TIMTEC-BB SBB002108;ART-CHEM-BB B006563;BUTTPARK 81\07-46;2,3'-DICHLORO-4-FLUOROACETANILIDE;2-CHLORO-N-(3-CHLORO-4-FLUOROPHENYL)ACETAMIDE;3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE;AKOS B006563
• CAS NO: 96980-64-2
• Molecular Formula: C₈H₆Cl₂FNO
• Molecular Weight: 222.04
• Mol File: 96980-64-2.mol
• Article Data: 35

Chemical Properties

• Melting Point: 96 °C
• Boiling Point: 363.2 °C at 760mmHg
• Flash Point: 173.5 °C
• Appearance: /
• Density: 1.479 g/cm³
• Vapor Pressure: 1.83E-05mmHg at 25°C
• Refractive Index: 1.584
• CAS DataBase Reference: 3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE(96980-64-2)
• EPA Substance Registry System: 3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE(96980-64-2)

Safety Data

• Hazard Codes: Xi
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 96980-64-2(Hazardous Substances Data)

Usage

General Description

3-Chloro-N-(chloroacetyl)-4-fluoroaniline is a chemical compound with the molecular formula C8H7Cl2FN. It is an organic compound that consists of a chloro group, a fluoro group, an amine group, and an acetyl group attached to the nitrogen atom. 3-CHLORO-N-(CHLOROACETYL)-4-FLUOROANILINE is commonly used in the synthesis of various pharmaceuticals and agrochemicals, as well as in the production of dyes and pigments. It is worth noting that this compound may pose health and environmental hazards, so caution is necessary when handling or using it.

InChI:InChI=1/C8H6Cl2FNO/c9-4-8(13)12-5-1-2-7(11)6(10)3-5/h1-3H,4H2,(H,12,13)

Upstream product

• 367-21-5 3-chloro-4-fluorophenylamine 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 141079-24-5 N-(3-Chloro-4-fluoro-phenyl)-2-(4-chloro-3-methyl-phenoxy)-acetamide 
• 100487-74-9 6-Chloro-5-fluoro-1,3-dihydro-2H-indol-2-one 
• 1236306-18-5 N-(3-chloro-4-fluorophenyl)-2-(4-(4-(pyridin-4-ylmethyl)phthalazin-1-yl)piperazin-1-yl)acetamide 
• 1236306-31-2 N-(3-chloro-4-fluorophenyl)-2-(4-(4-benzylphthalazin-1-yl)piperazin-1-yl)acetamide 
• 1387000-08-9 N-(3-chloro-4-fluorophenyl)-2-(6-methoxy-2-oxo-2H-chromen-7-yloxy)acetamide 
• 881555-19-7 2-(3-chloro-4-fluorophenylimino) thiazolidin-4-one 
• 881928-79-6 2-(3-chloro-4-fluorophenylimino)-5-(3-nitrobenzylidene)-4-thiazolidinone 
• 883278-52-2 2-(3-chloro-4-fluorophenylimino)-5-(4-hydroxybenzylidene)-4-thiazolidinone 
• 881937-91-3 2-(3-chloro-4-fluorophenylimino)-5-(4-chlorobenzylidene)-4-thiazolidinone 
• 881937-24-2 2-(3-chloro-4-fluorophenylimino)-5-(2-chlorobenzylidene)-4-thiazolidinone 
• 883278-32-8 2-(3-chloro-4-fluorophenylimino)-5-(benzylidene)-4-thiazolidinone 
• 881940-82-5 2-(3-chloro-4-fluorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)-4-thiazolidinone 

Relevant articles and documents

Synthesis, and in vitro biological evaluations of novel naphthoquinone conjugated to aryl triazole acetamide derivatives as potential anti-Alzheimer agents

Alzheimer's disease is a neurodegenerative disorder that deteriorates mental ability. Two main cholinesterases named, acetylcholinesterase and butyrylcholinesterase are potential targets against Alzheimer's disease. Cholinesterase inhibitors have benefici

New 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: synthesis, in vitro and in silico enzymatic and toxicity evaluations

Herein, a new series of 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors was designed and synthesized. All the synthesized compounds exhibited excellent inhibition potencies (IC50 values = 55.6–149.2 μM)

Design, synthesis and biological evaluation of novel 2,4-disubstituted quinazoline derivatives targeting H1975 cells via EGFR-PI3K signaling pathway

In order to find new and highly effective anti-tumor drugs with targeted therapeutic effects, a series of novel 4-aminoquinazoline derivatives containing N-phenylacetamide structure were designed, synthesized and evaluated for antitumor activity against four human cancer cell lines (H1975, PC-3, MDA-MB-231 and MGC-803) using MTT assay. The results showed that the compound 19e had the most potent antiproliferative activity against H1975, PC-3, MDA-MB-231 and MGC-803 cell lines. At the same time, compound 19e could significantly inhibit the colony formation and migration of H1975 cells. Compound 19e also arrested the H1975 cell cycle in the G1 phase and mediated cell apoptosis, promoted the accumulation of ROS in H1975 cells. Furthermore, compound 19e exerted antitumor effect in vitro by reducing the expression of anti-apoptotic protein Bcl-2 and increasing the pro-apoptotic protein Bax and p53. Mechanistically, compound 19e could significantly decreased the phosphorylation of EGFR and its downstream protein PI3K in H1975 cells. Which indicated that compound 19e targeted H1975 cell via interfering with EGFR-PI3K signaling pathway. Molecular docking showed that compound 19e could bind into the active pocket of EGFR. Those work suggested that compound 19e would have remarkable implications for further design of anti-tumor agents.